Matthew W. McClure

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

John P. DeVincenzo, Matthew W. McClure, Julian Symons et al. · New England Journal of Medicine · 2015 · 229 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary Syndrome

Matthew W. McClure, Scott D. Berkowitz, Rodney Sparapani et al. · Circulation · 1999 · 166 citations

Medicine, Cardiology, Hematology +17

A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y ₁₂ Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention

Robert C. Welsh, Sunil V. Rao, Uwe Zeymer et al. · Circulation Cardiovascular Interventions · 2012 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)

Sergio Leonardi, Sunil V. Rao, Robert A. Harrington et al. · American Heart Journal · 2010 · 79 citations

Medicine, Pharmacology, Pharmacotherapy +17

Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans

Kashyap Patel, Carl M. J. Kirkpatrick, Keith Nieforth et al. · Journal of Antimicrobial Chemotherapy · 2018 · 42 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17